Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)

China flag China · Delayed Price · Currency is CNY
7.14
-0.17 (-2.33%)
Feb 4, 2026, 3:08 PM CST
23.74%
Market Cap4.48B +24.5%
Revenue (ttm)691.16M -20.0%
Net Income-520.64M
EPS-0.81
Shares Out627.62M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume52,702,837
Average Volume50,812,287
Open8.01
Previous Close7.31
Day's Range7.01 - 8.01
52-Week Range4.60 - 10.07
Beta0.46
RSI55.93
Earnings DateApr 29, 2026

About SHE:300639

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/i... [Read more]

Sector Healthcare
Founded 2003
Employees 2,205
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300639
Full Company Profile

Financial Performance

Financial Statements